Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis- 24-Week Results Of A Phase 3 Double Blind Rando ...
Abstract
Authors
J. Sieper A. Kivitz A. van Tubergen A. Deodhar G. Coteur F. Woltering R. Landewé